<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: antibody responses</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>New 'adjuvant' could hold future of vaccine development</title>
   	 <description>Scientists at Oregon State University have developed a new "adjuvant" that could allow the creation of important new vaccines, possibly become a universal vaccine carrier and help medical experts tackle many diseases more effectively.</description>
     <link>http://www.physorg.com/news172171724.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 14 Sep 2009 18:40:02 EST</pubDate>
	 <guid isPermaLink="false">news172171724</guid>
</item>
<item>
     <title>Scientists identify genetic link that may neutralize HIV</title>
   	 <description>Scientists from the Gladstone Institute of Virology and Immunology (GIVI) and the National Institutes of Allergy and Infectious Diseases (NIAID) have identified a gene that may influence the production of antibodies that neutralize HIV. This new information will likely spur a new approach for making an HIV vaccine that elicits neutralizing antibodies. Neutralizing antibodies, once produced in the host, can attack and checkmate an infecting virus. The research was reported in the September 5 issue of Science.</description>
     <link>http://www.physorg.com/news139757724.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 04 Sep 2008 14:35:24 EST</pubDate>
	 <guid isPermaLink="false">news139757724</guid>
</item>


</channel>
</rss>

